AVADEL PHARMACEUTICALS PLC Quarterly Other Assets, Noncurrent in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Avadel Pharmaceuticals Plc quarterly Other Assets, Noncurrent history and growth rate from Q4 2014 to Q3 2024.
  • Avadel Pharmaceuticals Plc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $11.8M, a 15.9% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.8M +$1.61M +15.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $12M +$1.48M +14% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.8M +$837K +7.66% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $10.5M -$838K -7.4% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $10.1M -$1.57M -13.4% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $10.5M -$1.23M -10.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.9M -$28.7M -72.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $11.3M -$22.5M -66.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $11.7M -$26.4M -69.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $11.8M -$19.7M -62.6% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $39.6M +$11.9M +43% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $33.8M +$8.84M +35.4% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $38.1M +$15.8M +71.1% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $31.5M -$6.12M -16.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $27.7M -$19.8M -41.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $24.9M -$14.3M -36.5% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $22.3M -$12.7M -36.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $37.6M +$3.04M +8.8% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $47.5M +$11.4M +31.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $39.3M +$3.13M +8.65% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $34.9M +$10.1M +40.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $34.6M +$12.3M +55.4% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $36.1M +$15.9M +78.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $36.1M +$25.9M +253% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $24.8M +$15.8M +175% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $22.2M +$14M +170% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $20.2M +$12.7M +169% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $10.2M +$2.72M +36.1% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $9.02M +$2.2M +32.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $8.24M +$2.58M +45.6% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $7.53M +$7.52M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $7.53M +$7.36M +4410% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $6.82M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $5.66M Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $16K* Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $167K +$42K +33.6% Dec 31, 2015 10-K 2017-03-28
Q4 2014 $125K Dec 31, 2014 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.